GLP-1 Reality Check

Part one · What it actually costs

The real cash prices, no insurance required

Every price below is a manufacturer or licensed-pharmacy price you can pay out of pocket with a normal prescription. No insurance billed. FSA/HSA accepted at the manufacturer pharmacies, which knocks roughly 30% more off with pre-tax dollars.

Part one, continued

Find your situation

Five situations cover almost everyone. Find yours, get your number.

Insurance covers weight-loss GLP-1s

Run the prior authorization, then stack the manufacturer savings card on top.

$25–125/mo

Insurance, but weight loss is excluded

Skip discount coupons entirely. Take the direct-pay ladder above and pay with HSA/FSA. Ask HR about a rider at open enrollment.

$149–449/mo

No insurance at all

Same direct-pay ladder — none of it requires insurance. Add a telehealth visit fee for the prescription.

$149–449/mo

On Medicare

Check the new GLP-1 Bridge program first — live since July 2026, runs through 2027. BMI 35+, or 30+ with kidney disease/heart failure/uncontrolled hypertension, or 27+ with prediabetes or prior heart attack, stroke, or PAD. Manufacturer copay cards are off-limits to you.

$50/mo

Type 2 diabetes diagnosis

Ozempic or Mounjaro on the diabetes indication — the broadest coverage that exists. 60% of employers cover it.

$25/mo

Part two · The no-no sheet

Sellers with something on the record

Nobody lands here on rumor. Every entry below has a receipt: an FDA warning letter, a manufacturer or attorney-general lawsuit, an FTC action, or a criminal conviction. Ordered by how bad the documented harm is — not by how good anything is, because nothing here is being recommended.

The FDA warning-letter roster

All 165 companies below are named in published FDA warning letters covering peptide, semaglutide, tirzepatide, or retatrutide products. This is not a summary or a sample — it is pulled directly from the FDA's own warning-letter database export, and every letter is published individually on fda.gov where you can read it in full. A warning letter is a formal notice of violation carrying a 15-day response deadline; it is not itself a penalty, but failing to answer one can lead to seizure, injunction, civil penalties, or prosecution.

The shape of it is worth seeing: 110 of the 165 are telehealth companies cited for false or misleading claims — not shady overseas labs, but slick consumer-facing brands. Another 12 were cited for selling unapproved drugs over the internet, 8 are compounding pharmacies with adulterated products, and 7 are manufacturers with outright manufacturing violations.

Two tricks worth knowing before you read any product page

What the forums are saying — and why it sits in its own box

Vanished without notice

Royal Research · Peptide Tech Labs · American Research Labs · Unchained Compounds — all gone during the 2025 enforcement wave with no announcement. Science.bio closed voluntarily in January 2026, Strate Labs in July 2026 under a cease-and-desist order. In this market, the company holding your money can simply stop existing.

Part three · What independent labs actually found

Inside the vials

Not speculation. These are published findings from testing programs and from the manufacturer's own analysis of black-market product.

Part four · Why smart people get fooled

Five things that sound like proof and aren't

Research use only means it's a legit grade of product

It's a legal disclaimer, not a quality tier. It exists so the seller can argue they never sold a drug for human use. It guarantees nothing about the vial, and both the FDA and the courts have rejected it as a shield when the marketing points at consumers.

They post a COA, so it's tested

A purity certificate proves two things about a sample the vendor chose to send: the molecule's identity and its peptide-fraction purity. It does not test how many milligrams are in your vial — a 99% pure vial can be half-dosed — and it says nothing about sterility, endotoxin, heavy metals, or residual solvents. It also cannot prove your vial came from the batch that was tested. Purity is not safety.

FDA registered facility

Facility registration is a form any manufacturer files. The FDA does not inspect, endorse, or approve products because of it, and explicitly forbids using registration to imply approval. Treat this badge as a red flag, not a credential.

They have thousands of five-star reviews

Trustpilot flagged one major seller's profile for suspected fake reviews while it displayed 4.5 stars and held an F from the BBB with 227 complaints. Review scores in this market are a marketing surface.

They're selling retatrutide, so it must be available now

Retatrutide is approved nowhere on earth. Lilly won't even file it with the FDA until early 2027 — realistic pharmacy availability is 2028. Anyone selling it today is by definition selling an unregulated product of unknown contents. Same goes for cagrilintide and for “generic semaglutide”: no FDA-approved generic exists, and US patents run to December 2031.

Part four and a half · The question everyone asks

Are the certificates real?

Some are. Some are outright forgeries. You cannot tell by looking at one — but you can verify a real one in about sixty seconds, and almost nobody ever does.

Verify one yourself, in a minute

• Janoshik reports carry a QR code and a unique task ID — enter it on Janoshik's own site and it will confirm whether the report is authentic and unaltered. MZ Biolabs stamps a “Proof of Authenticity” code the same way.
• Email the lab directly with the report ID and ask if they tested that batch. Real labs answer.
• Match the lot number on your vial to the lot number on the COA. Different numbers mean that document does not describe what you're holding.

What a forged or worthless certificate looks like

• 100.0% purity. Analytically impossible. Even 99.99% should raise an eyebrow — real results look like 98.7% or 99.2%.
• HPLC purity with no mass spectrometry. HPLC says how pure it is; MS says what it actually is. A peptide missing one amino acid can read 99% pure and be the wrong compound entirely.
• One COA recycled across multiple batches, or a lot number that doesn't match the vial
• Every certificate identical except the peptide name and the purity number — that's a template, not a test
• A testing date that predates the vendor's own domain registration; check archive.org and the document falls apart
• The lab isn't named — or is named but has no independent existence you can find

Part five · Run this yourself

Red flags on any site, including ones nobody has listed yet

New sellers appear constantly and no list can stay ahead of all of them. This checklist can. Any one of these is a reason to walk.

• Sells retatrutide, cagrilintide, or “generic semaglutide” — none of these legally exist for sale in the US
• COAs are undated, not batch-specific, or from a lab that isn't named
• Shows “FDA registered facility,” “cGMP certified,” or ISO badges with no verifiable registration number
• Crypto-only or Zelle-only payment — no card processor will touch them
• Domain is under a year old; check it yourself on archive.org before you believe an “since 2015” claim
• Marketing winks at human use — weight-loss results, dosing charts — while the label says research only
• Only purity is published, never milligram quantification
• No sterility or endotoxin testing mentioned anywhere — nearly universal in this market, and the thing that matters most for anything injected

Part six · What's actually coming

The pipeline, so nobody has to buy a rumor

Most gray-market demand is for drugs that either just became cheap through legal channels, or don't exist yet at any price.